Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verso Biosense has developed a first-in-class smart intrauterine sensor platform ("IRIS") that provides real-time measurement of uterine biomarkers such as temperature and oxygen. Early clinical studies are ongoing to validate its use in fertility planning, endometriosis diagnostics, and broader women's health applications. The device is designed to empower both patients and clinicians with actionable data for personalized reproductive care. No published pivotal trial results or regulatory approvals yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verso Biosense.